A detailed history of Abrdn PLC transactions in Insmed Inc stock. As of the latest transaction made, Abrdn PLC holds 289,653 shares of INSM stock, worth $22.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
289,653
Previous 111,612 159.52%
Holding current value
$22.7 Million
Previous $8.15 Million 145.45%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$66.29 - $76.63 $11.8 Million - $13.6 Million
178,041 Added 159.52%
289,653 $20 Million
Q2 2024

Aug 09, 2024

SELL
$22.0 - $69.71 $481,514 - $1.53 Million
-21,887 Reduced 16.39%
111,612 $7.48 Million
Q1 2024

May 08, 2024

BUY
$25.72 - $29.94 $861,594 - $1 Million
33,499 Added 33.5%
133,499 $3.62 Million
Q4 2023

Jan 31, 2024

BUY
$23.42 - $31.74 $2.34 Million - $3.17 Million
100,000 New
100,000 $3.1 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.